GSK strengthens R&D partnerships for novel drugs with Korean research centers

Published: 2017-11-07 15:10:09

Updated: 2017-11-07 15:10:09

GSK Korea(CEO/President Yoo-Seok Hong) held a MOU ceremony with Yonsei University College of Medicine Songdang Cancer Center(Director Hyun-Cheol Jung) on the 2^nd and announced they will strengthen a mutual cooperation to jointly study and develop innovative anticancer therapies.

Under the agreement, GSK is planning to expand Phase I and Phase II clinical trial development programs and conduct ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.